Status:
UNKNOWN
Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis
Lead Sponsor:
GMG Grand Medical
Collaborating Sponsors:
Gama CRO Tıbbi İlaç Araştırma Org.Tic.Ltd.Şti
Conditions:
Quality of Life
Infection, Bacterial
Eligibility:
MALE
18-79 years
Brief Summary
Multicenter, Retrospectivecohort study in patients with Chronic Prostatitis, Chronic Bacterial Prostatitis (Category II) and Chronic Pelvic Pain Syndrome (Category IIIA, IIIB) and 140 patients without...
Detailed Description
This study will be conducted in Patients with Confirmed Chronic Prostatitis and the datas of these patients will be recorded. In real clinical practice, the data of patients who received Treataprost ...
Eligibility Criteria
Inclusion
- Patients must be ≥ 18 years old and male.
- The participant must be willing and competent to give written informed consent. If the subject is unable to consent on his behalf, a legally acceptable representative (ie, acceptable to the International Council for Harmonization \[ICH\] and local law as appropriate) must give informed consent on his behalf.
- Chronic Prostatitis, Chronic Bacterial Prostatitis (Category II) and Chronic Pelvic Pain Syndrome (Category IIIA, IIIB) diagnosed with standard antibiotic therapy with NSAID and antibiotic therapy with NSAID together with Treataprost patients
Exclusion
- In patients with Chronic Prostatitis, Chronic Bacterial Prostatitis (Category II) and Chronic Pelvic Pain Syndrome (Category IIIA, IIIB) not receiving any treatment
- For Chronic Prostatitis, Chronic Bacterial Prostatitis (Category II) and Chronic Pelvic Pain Syndrome (Category IIIA, IIIB) taking an herbal preparation other than Treataprost in addition to standard antibiotic therapy and NSAID
- Patients who have participated in any clinical trial and received an investigational product
- Patients who did not give written informed consent
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05306314
Start Date
April 15 2022
End Date
October 15 2023
Last Update
April 1 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
18 Mart University Faculty of Medicines
Çanakkale, Turkey (Türkiye), 17020
2
TR Ministry of Health Eskişehir City Hospital
Eskişehir, Turkey (Türkiye), 26080
3
Süleyman Demirel University Faculty of Medicines
Isparta, Turkey (Türkiye), 32260
4
Manisa Celal Bayar University Hafsa Sultan Hospital
Manisa, Turkey (Türkiye), 45030